A multicenter open-label experience on the response of psoriasis to Adalimumab and effect of dose escalation in non-responders: the Aphrodite project.

Source:http://linkedlifedata.com/resource/pubmed/id/19309570

Download in:

View as

General Info

PMID
19309570